A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Clinical trial NCT07184086 · RECRUITING
Trial details
- NCT number
- NCT07184086
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-26
- Primary completion
- 2027-10-12
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.